MedTrace Logo

Does Allopurinol Prolong a Treated, Acute Gout Flare?

NCT01988402 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-02-14

Study results available
· View outcomes & findings →

Summary

This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.

Conditions

Interventions

DRUG

allopurinol

DRUG

Placebo (sugar pill)

Sponsors & Collaborators

  • United States Air Force

    collaborator FED

  • 59th Medical Wing

    lead FED

Principal Investigators

  • Jay B Higgs, MD · 59th Medical Wing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01988402 on ClinicalTrials.gov